As of January 22, 2025, Sana Biotechnology (SANA) has a market cap of $0.78 billion USD. According to our data, Sana Biotechnology is ranked No.5562 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.78 B |
114.72%
|
Dec 31, 2024 | $0.36 B |
-60.05%
|
Dec 29, 2023 | $0.91 B |
3.29%
|
Dec 30, 2022 | $0.88 B |
-74.48%
|
Dec 31, 2021 | $3.46 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
Replimune
REPL
|
$1.00 B |
-0.000 M
|
USA
|
Atara Biotherapeutics
ATRA
|
$39.68 M |
0.000 M
|
USA
|
Market Cap | = | SANA Stock Price | * | SANA Shares Outstanding |
= | $3.50 | * | 0.22 B | |
= | $0.78 B |